• Prime Medicine launched an underwritten public offering of $125 million of common stock, with all shares offered by the company.
• Underwriters would receive a 30-day option to purchase up to an additional $18.75 million of common stock.
• Jefferies, TD Cowen and Goldman Sachs are joint book-running managers.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Prime Medicine Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202611101605PRIMZONEFULLFEED9874882) on November 10, 2026, and is solely responsible for the information contained therein.